Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

European Perioperative Brugada Survey

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04808193
Recruitment Status : Recruiting
First Posted : March 22, 2021
Last Update Posted : November 9, 2021
Sponsor:
Information provided by (Responsible Party):
Universitair Ziekenhuis Brussel

Study Description
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
The aim of this survey is to assess the current perception and clinical practice of Resident and Board-certified Anaesthesiologists and Intensivists regarding perioperative care of patients burdened with the Brugada Syndrome. It is intended to investigate this primarily on national and secondarily on European level.

Condition or disease Intervention/treatment Phase
Brugada Syndrome Other: Survey Not Applicable

Study Design
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 300 participants
Allocation: N/A
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Health Services Research
Official Title: European Perioperative Brugada Survey
Actual Study Start Date : March 31, 2021
Estimated Primary Completion Date : December 31, 2021
Estimated Study Completion Date : December 31, 2021

Resource links provided by the National Library of Medicine


Arms and Interventions
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Arm Intervention/treatment
Experimental: Brugada Survey
Survey will be answered by all participants
 Other: Survey
Participants will fill in the survey


Outcome Measures
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. Questionnaire about treatments for Brugada patients [ Time Frame: 1 hour ]
    Number of participants with treatment-related information as assessed by the survey/questionnaire N/A


Eligibility Criteria
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • All participants must have received an invitation to participate in the survey through the online platform of the European Society of Anaesthesiology and Intensive Care.

Exclusion Criteria:

  • Uninvited participation in the survey is not possible.
Contacts and Locations
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04808193


Contacts
Layout table for location contacts
Contact: Evelien Vandeurzen 192 92 37 evelien.vandeurzen@uzbrussel.be

Locations
Layout table for location information
Belgium
UZ Brussel Recruiting
Jette, Brussel, Belgium, 1090
Contact: Evelien Vandeurzen, Master    024749237    evelien.vandeurzen@uzbrussel.be   
Principal Investigator: Panagiotis Flamée, MD         
Sub-Investigator: Hugo Carvalho, MD         
Sub-Investigator: Jan Poelaert, MD, PhD         
Sponsors and Collaborators
Universitair Ziekenhuis Brussel
More Information
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Layout table for additonal information
Responsible Party: Universitair Ziekenhuis Brussel
ClinicalTrials.gov Identifier: NCT04808193    
Other Study ID Numbers: EUPerBrugadaSurvey
First Posted: March 22, 2021    Key Record Dates
Last Update Posted: November 9, 2021
Last Verified: March 2021
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Brugada Syndrome
Arrhythmias, Cardiac
Heart Diseases
 Cardiovascular Diseases
Cardiac Conduction System Disease
Genetic Diseases, Inborn